Daniel Phelan has more than three decades’ experience with GlaxoSmithKline, half that time as member of the company’s corporate executive team. As GSK’s chief of staff, Phelan was advisor to three chief executives and had global responsibility for corporate strategy & development, information technology, facilities, security, environmental health & safety, human resources, and employee health & safety. He retired from GSK in 2012.

Phelan is a Board Director of TE Connectivity (formerly Tyco Electronics), and is chairman of the company’s management development & compensation committee. He is also a board member of Indivior, a member of the advisory board of G&W Laboratories, and is a member of Rutgers University’s Board of Trustees.

A graduate of Rutgers College, Phelan earned an MA from The Ohio State University and a JD from Rutgers University School of Law.

Dan was named to the Board of Trustees of Rutgers University in 2013, and has been a member of the Board of Overseers since 2009. He is a member of the Boards of WHYY, Greater Philadelphia’s leading public media provider and The Fairmount Park Conservancy, which oversees the park system for the city of Philadelphia. He was co-chair of the Corporate Executive Board of the Philadelphia Museum of Art from 2011-2012. He has also been a lecturer on comparative corporate governance at the Rutgers University School of Management and Labor Relations Executive Master’s Program. He was the recipient of the 2010 Distinguished Alumni Award from Rutgers University Law School.

Dan has published in the areas of CEO succession and onboarding and public sector collective bargaining. His most recent publications are “Picking the Right Insider for CEO Succession” in the January 2009 Harvard Business Review and “Vision and Substance: The CHRO’s Role in Successful CEO Onboarding” in HR Directions 2015.